How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements

BACKGROUND: New drugs including cancer drugs and orphan drugs are becoming increasingly more expensive. Risk sharing arrangements (RSAs) could manage the risk based on both financial impact and the health outcome of new drugs if reimbursed. To improve patients’ access to new drugs under uncertaintie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Boram, Bae, Eun-Young, Bae, SeungJin, Choi, Hyun-Jin, Son, Kyung-Bok, Lee, Young-Sil, Jang, Suhyun, Lee, Tae-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442279/
https://www.ncbi.nlm.nih.gov/pubmed/34521408
http://dx.doi.org/10.1186/s12913-021-06919-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442279/
https://www.ncbi.nlm.nih.gov/pubmed/34521408
http://dx.doi.org/10.1186/s12913-021-06919-x

Ejemplares similares